Skip to main content
. Author manuscript; available in PMC: 2018 Apr 2.
Published in final edited form as: J Appl Clin Med Phys. 2017 May 14;18(4):76–83. doi: 10.1002/acm2.12099

Table 1.

Characteristics of Patients, Tumors, and Treatment

Patient Location Stage Histology Treatment With Prescription Dose (Gy/Fractions) CTVHigh Volume (cc)
1 Hard palate T4bN0 ACC* ChemoRT (70/35) 242
2 Nasopharynx T1N0 SCC* RT (70/33) 37
3 Base of Tongue T2N2b SCC Surgery+ChemoRT (70/35) 35
4 Left buccal mucosa T1N1 SCC Surgery+ChemoRT (60/30) 243
5 Oral Tongue T1N1 SCC Surgery+RT (60/30) 47
6 Oral Tongue T2N2b SCC Surgery+ChemoRT (70/35) 41
7 Base of tongue T2/T3N2b SCC ChemoRT (70/35) 265
8 Nasopharynx T4N2 SCC ChemoRT (70/33) 79
9 Supraglottis T2N2c SCC RT (66/33) 113
10 Left Mandible T2N0 SCC Surgery+RT (60/30) 72

Abbreviations:

*

ACC: adenocarcinoma; SCC: squamous cell carcinoma; ChemoRT: chemoradiotherapy; RT: radiation therapy